Suzanne Egyhazi Brage
Senior Research Specialist
E-mail: suzanne.egyhazi.brage@ki.se
Visiting address: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Helgadottir, 171 77 Stockholm
About me
- I have a PhD in experimental oncology. My main focus is to find novel
biomarkers for durable benefit from targeted therapies and immunotherapies
and novel targets to overcome drug resistance in cutaneous malignant
melanoma.
Articles
- Article: IMMUNO-ONCOLOGY AND TECHNOLOGY. 2024;22:100713
- Article: ACTA ONCOLOGICA. 2023;62(12):1921-1930
- Article: CANCERS. 2022;14(3):702
- Article: ACTA ONCOLOGICA. 2022;61(1):14-21
- Article: GENETICS IN MEDICINE. 2022;24(1):157-169
- Article: SCIENTIFIC REPORTS. 2021;11(1):11023
- Article: CANCER RESEARCH. 2021;81(9):2545-2555
- Article: CELL DEATH & DISEASE. 2020;11(10):882
- Article: MELANOMA RESEARCH. 2020;30(5):443-454
- Article: CELL DEATH AND DIFFERENTIATION. 2020;27(7):2081-2098
- Article: CELL DEATH & DISEASE. 2019;10(9):663
- Article: MOLECULAR SYSTEMS BIOLOGY. 2018;14(3):e7858
- Article: BRITISH JOURNAL OF CANCER. 2018;118(4):480-488
- Article: PLOS ONE. 2018;13(11):e0206942
- Article: CELLULAR ONCOLOGY. 2017;40(6):631-638
- Article: CELL DEATH & DISEASE. 2017;8(8):e3029
- Article: ONCOTARGET. 2017;8(13):21539-21553
- Article: CELL REPORTS. 2016;15(9):2000-2011
- Article: CLINICAL CANCER RESEARCH. 2016;22(1):146-157
- Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(12):2844-2853
- Article: ANNALS OF ONCOLOGY. 2015;26(1):81-88
- Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2014;24(8):1389-1394
- Article: MATRIX BIOLOGY. 2014;38:69-83
- Article: BRITISH JOURNAL OF CANCER. 2014;110(10):2489-2495
- Journal article: ANNALS OF ONCOLOGY. 2014;25:i5
- Article: MELANOMA RESEARCH. 2013;23(6):452-460
- Article: BMC CLINICAL PATHOLOGY. 2013;13(1):30
- Article: MELANOMA RESEARCH. 2013;23(5):360-365
- Article: CANCER RESEARCH. 2013;73(13):3877-3887
- Article: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(3):448-455
- Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2010;130(12):2809-2817
- Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2010;130(8):2062-2070
- Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2009;58(7):1085-1094
- Article: PIGMENT CELL & MELANOMA RESEARCH. 2009;22(2):196-204
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2009;27(4):526-534
- Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2008;128(11):2696-2704
- Article: MOLECULAR CANCER THERAPEUTICS. 2008;7(9):2876-2883
- Article: CANCER RESEARCH. 2007;67(19):9006-9012
- Article: MELANOMA RESEARCH. 2006;16(6):471-478
- Article: CLINICAL CHEMISTRY. 2005;51(12):2388-2391
- Article: CLINICAL CANCER RESEARCH. 2005;11(8):2991-2997
- Article: BREAST CANCER RESEARCH. 2005;7(6):R953-R964
- Article: BRITISH JOURNAL OF CANCER. 2003;89(8):1517-1523
- Article: HUMAN MUTATION. 2002;20(5):408-409
- Article: ONCOLOGY REPORTS. 2002;9(5):1015-1019
- Article: MELANOMA RESEARCH. 2002;12(4):335-342
- Article: EUROPEAN JOURNAL OF CANCER. 1997;33(3):447-452
- Article: EUROPEAN JOURNAL OF CANCER. 1997;33(1):129-134
- Article: EUROPEAN JOURNAL OF CANCER. 1996;32A(13):2319-2326
- Article: ACTA ONCOLOGICA. 1996;35(6):683-690
- Article: ANTI-CANCER DRUGS. 1995;6(5):657-668
- Journal article: CANCER RESEARCH. 1993;53(18):4257-4261
- Journal article: EUROPEAN JOURNAL OF CANCER. 1991;27(12):1658-1662
- Show more
All other publications
- Conference publication: ANNALS OF ONCOLOGY. 2023;34:S688-S689
- Letter: ACTA ONCOLOGICA. 2022;61(9):1116-1120
- Meeting abstract: ANNALS OF ONCOLOGY. 2022;33(7):S945
- Letter: ACTA ONCOLOGICA. 2022;61(7):869-873
- Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(3 PT A):736-740.e6
- Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15):9556
- Conference publication: ANNALS OF ONCOLOGY. 2019;30:xi8-xi9
- Meeting abstract: ANNALS OF ONCOLOGY. 2019;30:vii8
- Conference publication: ANNALS OF ONCOLOGY. 2019;30:v559
- Meeting abstract: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2019;139(9):s298
- Conference publication: ANNALS OF ONCOLOGY. 2019;30:559
- Conference publication: CANCER IMMUNOLOGY RESEARCH. 2018;6(9):a14
- Meeting abstract: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2018;138(5):S200
- Conference publication: ANNALS OF ONCOLOGY. 2017;28:v437
- Conference publication: CANCER RESEARCH. 2017;77:p1-07-16-p1-07-16
- Conference publication: ANNALS OF ONCOLOGY. 2017;28
- Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(9):s245
- Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):9579
- Conference publication: CANCER RESEARCH. 2016;76:B28
- Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(9):S245
- Conference publication: CANCER RESEARCH. 2015;75:p6-08-03-p6-08-03
- Review: PHARMACOLOGY & THERAPEUTICS. 2014;142(2):176-182
- Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134(1):287-290
- Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2012;48:43
- Conference publication: ANNALS OF ONCOLOGY. 2012;23:v27
- Conference publication: ANNALS OF ONCOLOGY. 2012;23:v23
- Conference publication: ANNALS OF ONCOLOGY. 2012;23:27
- Conference publication: ANNALS OF ONCOLOGY. 2012;23:23
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):8551
- Conference publication: CANCER RESEARCH. 2011;71:3495
- Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2010;130(2):618-620
- Conference publication: CANCER RESEARCH. 2009;69
- Review: MOLECULAR ONCOLOGY. 2008;1(4):395-405
- Conference publication: PIGMENT CELL & MELANOMA RESEARCH. 2008;21(2):285
- Conference publication: ANNALS OF ONCOLOGY. 2008;19:243
- Corrigendum: CANCER RESEARCH. 2008;68(4):1245
- Conference publication: MELANOMA RESEARCH. 2007;17(1):a10-a11
- Conference publication: MELANOMA RESEARCH. 2007;17(1):a1-a2
- Conference publication: MELANOMA RESEARCH. 2007;17(1):a18-A19
- Conference publication: MELANOMA RESEARCH. 2007;17(1):a17-a18
- Conference publication: MELANOMA RESEARCH. 2007;17(1):a21-a22
- Conference publication: MELANOMA RESEARCH. 2006;16(Supplement 1):s26
- Conference publication: MELANOMA RESEARCH. 2006;16(Supplement 1):s61-s62
- Conference publication: CANCER RESEARCH. 2006;66(8)
- Conference publication: CANCER RESEARCH. 2006;66(8)
- Conference publication: MELANOMA RESEARCH. 2004;14(4):a21-a22
- Conference publication: MELANOMA RESEARCH. 2004;14(4):a11
- Letter: CLINICAL CHEMISTRY. 2004;50(5):975-976
- Conference publication: BREAST CANCER RESEARCH AND TREATMENT. 2002;76:S29
- Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2001;69(4):418
- Conference publication: MELANOMA RESEARCH. 1999;9(3):329
- Conference publication: MELANOMA RESEARCH. 1997;7(Supplement 1):s115
- Conference publication: MELANOMA RESEARCH. 1997;7(2):161
- Thesis / dissertation: 1996
- Other: BRITISH JOURNAL OF CANCER. 1995;71(1):37-39
- Show more
Grants
- Translational studies on cutaneous malignant melanomaKonung Gustaf V:s Jubileumsfond1 January 2021 - 31 December 2022
- Translational studies on cutaneous malignant melanomaKonung Gustaf V:s Jubileumsfond1 January 2018 - 31 December 2020
- Clinical and molecular genetic studies of malignant melanomaKonung Gustaf V:s Jubileumsfond1 January 2015
- Swedish Research Council1 January 2014 - 31 December 2016
- Explore the effect of inflammation proteins on clinical outcome to treatment with anti-PD1 in metastatic cutaneous melanomaKarolinska Institutet
- New combination therapeutic strategy by targeting MET and EGFR/HER2 in malignant melanomaKarolinska Institutet